Levonorgestrel
Showing 51 - 75 of 481
Control of Bleeding on Nexplanon in Latinx Patients
Not yet recruiting
- Contraception
- 150 mcg levonorgestrel/30 mcg ethinyl estradiol
- (no location specified)
Nov 1, 2021
Bioequivalence Trial in Santiago (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Levonorgestrel 15.0 mg and
Completed
- Bioequivalence
- Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
- Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Reference Product
-
Santiago, ChileInnolab
Feb 8, 2021
Bioequivalence Trial in Santiago (Levonorgestrel 0.1 mg and Ethinyl estradiol 0.02 mg Test Product, Levonorgestrel 0.1 mg and
Completed
- Bioequivalence
- Levonorgestrel 0.1 mg and Ethinyl estradiol 0.02 mg Test Product
- Levonorgestrel 0.1 mg and Ethinyl estradiol 0.02 mg Reference Product
-
Santiago, ChileInnolab
Feb 8, 2021
Healthy Adults Trial in Anaheim (PF-06882961, Atorvastatin, Midazolam)
Completed
- Healthy Adults
- PF-06882961
- +3 more
-
Anaheim, CaliforniaAnaheim Clinical Trials, LLC
Jul 21, 2022
HIV, Contraception Trial in Kampala (Levonorgestrel, Efavirenz)
Completed
- HIV
- Contraception
- Levonorgestrel
- Efavirenz
-
Kampala, UgandaInfectious Diseases Institute
Jan 20, 2021
Pharmacokinetics, Pharmacodynamics Trial in Moenchengladbach (laquinimod, Placebo)
Completed
- Pharmacokinetics
- Pharmacodynamics
- laquinimod
- Placebo
-
Moenchengladbach, GermanyTeva Investigational Site 32415
Nov 5, 2021
Tubal Ligation Trial in Assiut (Levonorgestrel-releasing intrauterine system)
Recruiting
- Tubal Ligation
- Levonorgestrel-releasing intrauterine system
-
Assiut, EgyptWomen Health Hospital - Assiut university
Dec 5, 2020
Pregnancy Rates, PK Interactions Among HIV+ Women on EFV
Completed
- HIV Infections
-
Lilongwe, MalawiUNC Project
Feb 23, 2022
Adenomyosis, Chronic Pelvic Pain Trial (LNG-IUS 13,5 mg Levonorgestrel, Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg)
Unknown status
- Adenomyosis
- Chronic Pelvic Pain
- LNG-IUS 13,5 mg Levonorgestrel
- Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg
- (no location specified)
Feb 3, 2021
Mucosal Inflammation, Contraceptive; Complications, Intrauterine Trial in Norfolk, Thika (Copper IUD, Etonogestrel implant,
Recruiting
- Mucosal Inflammation
- Contraceptive; Complications, Intrauterine
- Copper IUD
- +3 more
-
Norfolk, Virginia
- +1 more
Apr 7, 2022
HIV-1-infection Trial in Reutov (Elpida®, Rifampin, Rifabutin)
Completed
- HIV-1-infection
- Elpida®
- +6 more
-
Reutov, Moscow Region, Russian FederationCentral Clinical City Hospital
Jan 10, 2022
Endometrial Hyperplasia Without Atypia Trial in Kocaeli (Vaginal Micronized Progesterone, Levonorgestrel-Intrauterine System)
Completed
- Endometrial Hyperplasia Without Atypia
- Vaginal Micronized Progesterone
- Levonorgestrel-Intrauterine System
-
Kocaeli, TurkeyKocaeli University
Dec 1, 2020
Immune Cells in Women Using Contraception (CHIC II)
Completed
- HIV
- +2 more
- levonorgestrel exposure
- +4 more
-
Pittsburgh, PennsylvaniaCenter for Family Planning Research
Dec 22, 2021
Relapsing Multiple Sclerosis (RMS) Trial in Germany, Poland (Cladribine, Placebo, Microgynon®)
Active, not recruiting
- Relapsing Multiple Sclerosis (RMS)
- Cladribine
- +2 more
-
Bochum, Germany
- +6 more
Feb 8, 2022
Sites to Test Whether SAMANTA Questionnaire That is Used to
Completed
- Menorrhagia
- Chronic hormonal treatment
-
Multiple Locations, SpainMany locations
Mar 29, 2022
Contraception Trial in Ireland, United Kingdom, United States (CDB-2914, Levonorgestrel)
HIV, Contraception, Drug-drug Interaction Trial in Eldoret (Cabotegravir/ Rilpivirine, Etonogestrel (ETG) implant, Intramuscular
Recruiting
- HIV Infections
- +2 more
- Cabotegravir/ Rilpivirine
- +4 more
-
Eldoret, KenyaAcademic Model Providing Access to Healthcare (AMPATH) Moi Teach
Mar 30, 2022
Diabetes, Type 2 Trial in Berlin (Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL)
Recruiting
- Diabetes Mellitus, Type 2
- Semaglutide 1.34 mg/mL
- +4 more
-
Berlin, GermanyNovo Nordisk Investigational Site
Jan 3, 2022
Incomplete Abortion, Intrauterine Contraception, Misoprostol Trial in Wakiso (Use of either copper T380A or Levonorgestrel LNG
Not yet recruiting
- Incomplete Abortion
- +2 more
- Use of either copper T380A or Levonorgestrel LNG 52 IUS after medical management of first trimester incomplete abortion
-
Wakiso, Central, UgandaHerbert Kayiga
Apr 20, 2022
Hormonal Contraceptive Methods on Immunologic Changes in Female
Recruiting
- Hormonal Contraception
- Depot medroxyprogesterone acetate (DMPA)
- +2 more
-
Atlanta, Georgia
- +2 more
Aug 15, 2022
Overweight, Obesity Trial in Montreal (NNC0174-0833, Oral contraceptive (OC) tablets, Acetaminophen)
Completed
- Overweight
- Obesity
- NNC0174-0833
- +2 more
-
Montreal, Quebec, CanadaNovo Nordisk Investigational Site
Jan 6, 2022
Endometrial Cancer, Atypical Endometrial Hyperplasia Trial in Chengdu (Progesterone, Mirena®, GnRH agonist)
Recruiting
- Endometrial Cancer
- Atypical Endometrial Hyperplasia
- Progesterone
- +2 more
-
Chengdu, Sichuan, ChinaWest China Second University Hospital
Sep 3, 2021
Healthy Subjects Trial in Rennes (Combined oral contraceptives (COC), Moxifloxacin 400mg, Cenerimod 0.5 mg)
Completed
- Healthy Subjects
- Combined oral contraceptives (COC)
- +5 more
-
Rennes, FranceSite 1
Nov 15, 2022